Quick Answer
Jaguar Health, Inc. reported Cash and Equivalents of $8.00 million for fiscal year 2024.
Jaguar Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $8.00M | +23.7% |
| 2023 | $6.47M | +18.3% |
| 2022 | $5.47M | -67.9% |
| 2021 | $17.05M | +110.8% |
| 2020 | $8.09M | +131.5% |
| 2019 | $3.50M | +36.1% |
| 2018 | $2.57M | +393.2% |
| 2017 | $520.7K | -45.2% |
| 2016 | $951.0K | -87.6% |
| 2015 | $7.70M | +810.7% |
| 2014 | $845.2K | +356.0% |
| 2013 | $185.4K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.53M | -73.4% | +59.8% |
| June 30, 2025 | $2.21M | -86.2% | -61.2% |
| March 31, 2025 | $5.69M | -51.2% | -28.9% |
| December 31, 2024 | $8.00M | +23.7% | -39.7% |
| September 30, 2024 | $13.27M | +311.3% | -17.3% |
| June 30, 2024 | $16.05M | +86.0% | +37.5% |
| March 31, 2024 | $11.67M | -18.8% | +80.4% |
| December 31, 2023 | $6.47M | +18.3% | +100.5% |
- Jaguar Health, Inc. showed an increase of +23.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2013–2024 period, Jaguar Health, Inc.’s cash and equivalents has grown by 4216.8% (from $185.4 thousand to $8.00 million).
- The most recent figure is from Jaguar Health, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: